Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients

BACKGROUND: Limited data exist regarding mucosal healing (MH) and therapeutic drug monitoring (TDM) in pediatric Crohn's disease (CD) patients treated with adalimumab (ADL). We aimed to investigate the associations between ADL trough levels (TLs) and MH, and between ADL TLs and histologic remis...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, So Yoon, Choi, Young Ok, Choe, Yon Ho, Kang, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183843/
https://www.ncbi.nlm.nih.gov/pubmed/32329259
http://dx.doi.org/10.3346/jkms.2020.35.e114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183843/
https://www.ncbi.nlm.nih.gov/pubmed/32329259
http://dx.doi.org/10.3346/jkms.2020.35.e114

Ejemplares similares